ISOThrive Revenue and Competitors
Estimated Revenue & Valuation
- ISOThrive's estimated annual revenue is currently $1.9M per year.
- ISOThrive's estimated revenue per employee is $155,000
Employee Data
- ISOThrive has 12 Employees.
- ISOThrive grew their employee count by 0% last year.
ISOThrive's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, Chief Technology Officer & CEO | Reveal Email/Phone |
2 | Co-Founder and Co-Chief Medical Officer | Reveal Email/Phone |
3 | Co-Founder and Co-Chief Medical Officer | Reveal Email/Phone |
4 | VP & Chief Science Officer | Reveal Email/Phone |
5 | VP Clinical Research Operations | Reveal Email/Phone |
6 | VP/Director Medical Research | Reveal Email/Phone |
7 | Clinical Research Project Manager | Reveal Email/Phone |
8 | Bioprocess Research Scientist | Reveal Email/Phone |
ISOThrive Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $4.3M | 28 | 4% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $3.5M | 45 | -52% | $56.5M | N/A |
#5 | $0.3M | 2 | 0% | N/A | N/A |
#6 | $4.5M | 29 | 21% | N/A | N/A |
#7 | $1.9M | 12 | 9% | N/A | N/A |
#8 | $7M | 45 | 5% | N/A | N/A |
#9 | $6.7M | 43 | 5% | N/A | N/A |
#10 | $2M | 13 | -13% | N/A | N/A |
What Is ISOThrive?
We treat chronic disease caused by microbiome dysbiosis. Our first indication affects 1/3 US population and presents a $16B annual market opportunity. Beyond that, we have disrupted drug discovery with a shorter timeline to market, faster investment return and relatively small up front investment. With our Lightning Rapid Carbohydrate Drug Discovery Platform, we have a pipeline of novel MIMOs targeting a range of upper and lower GI conditions.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | 0% | N/A |
#2 | $1M | 12 | -20% | N/A |
#3 | $2.1M | 13 | -7% | N/A |
#4 | $1.2M | 14 | 17% | N/A |
#5 | $1.2M | 14 | -36% | N/A |